P. Masarachia

Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation <i>in vitro</i>

John Fisher, Michael J. Rogers, J. M. Halasy et al. · Proceedings of the National Academy of Sciences · 1999 · 679 citations

Medicine, Biochemistry, Pharmacology +17

Alendronate Is a Specific, Nanomolar Inhibitor of Farnesyl Diphosphate Synthase

James D. Bergstrom, Richard G. Bostedor, P. Masarachia et al. · Archives of Biochemistry and Biophysics · 2000 · 401 citations

Medicine, Medicinal Chemistry, Pharmacology +7

Bisphosphonates Act Directly on the Osteoclast to Induce Caspase Cleavage of Mst1 Kinase during Apoptosis

Alfred A. Reszka, Judit Halasy-Nagy, P. Masarachia et al. · Journal of Biological Chemistry · 1999 · 257 citations · Full text

Medicine, Pharmacology, Apoptosis +16

Comparison of the distribution of 3H-alendronate and 3H-Etidronate in rat and mouse bones

P. Masarachia, Miron Weinreb, R. Balena et al. · Bone · 1996 · 248 citations

Medicine, Pharmacology, Bone Metabolism +10

Bone density, strength, and formation in adult cathepsin K (−/−) mice

Brenda L Pennypacker, M. Shea, Q. Liu et al. · Bone · 2008 · 147 citations

Medicine, Animal Sciences, Orthopaedic Surgery +12